{"retracted":false,"update":{"timestamp":1485907200000,"doi":"10.1007/s40267-017-0376-z","type":"correction"},"doi":"10.1007/s40267-016-0368-4","journal":"Drugs & Therapy Perspectives","publisher":"Springer Nature","title":"Erratum to: Tafamidis in transthyretin amyloidosis: a guide to its use in delaying peripheral neurological impairment in patients with stage 1 polyneuropathy"}
